FDA approves next phase of medical breakthrough in kidney transplants

@WDRBNews reports on Talaris’ Phase 3 trial initiation which will bring our cell therapy to hospitals across the country. Hear from a trial participant about what this treatment means for his life, and for his son who also carries a gene for kidney disease: FULL STORY and video